Premont obtained his B.S. in Biology and Chemistry at the California Institute of Technology in 1985, and M.Ph . and Ph.D. in Biomedical Sciences (Pharmacology) at Mount Sinai School of Medicine (City University In our work, we utilize methods including structural biology and proteomics, molecular biology and biochemical

Chemical biologist Johannes Broichhagen reveals how fluorescent probes transform GPCR imaging, internalization GPCR Podcast, chemical biologist Dr. Why this matters How a chemist with zero biology training became a leader in GPCR probe design. Who should listen If you’ve ever: Navigated a project where the biology refused to match the textbook Collaborated across chemistry and biology and felt the translation gap firsthand… …this episode will

program in the Department of Pharmaceutical Sciences at the Faculty of Pharmacy and the Department of Biochemistry He is the scientific founder of two biotech companies, ModMab Therapeutics , and AntlerA Therapeutics Angers was named Director of the Donnelly Centre of Cellular and Biomolecular Research at the University

Duke Distinguished Professor of Medicine and Biochemistry at Duke University, where he has led his laboratory rich pharmacological toolkit and cardiovascular relevance, made it the right platform for receptor biochemistry The cloning race and the serendipity of the intronless gene — Competing against Genentech's molecular biology When Brian Kobilka proposed screening a genomic library, Merck's molecular biology collaborators called Duke Professor of Medicine and Professor of Biochemistry, Chemistry, and Pathology at the Duke University

culture of normal and malignant pancreatic tissue, allowing advances in sequencing, target discovery and biomarker interest in science originated from a young age and his desire to gain more knowledge about cancer biology They also shared their personal experiences and interest in the field of biology. proposed further exploration of dosage and length of treatment in a mouse model and suggested using a biosensor-based

tissue-specific engagement Who should listen Navigated complex datasets where interpretation depended on biological His group develops imaging and chemical biology tools to reveal how GLP-1 and GIP receptors operate within David Hodson on the Web Radcliffe Department of Medicine Islet Biology Lab University of Birmingham Unlock

Premont obtained his B.S. in Biology and Chemistry at the California Institute of Technology in 1985, and M.Ph . and Ph.D. in Biomedical Sciences (Pharmacology) at Mount Sinai School of Medicine (City University In our work, we utilize methods including structural biology and proteomics, molecular biology and biochemical

not just sequence matches — is non-trivial, and it matters for anyone hoping to translate kidney OR biology She received her undergraduate degree in biology from Truman State University and earned her Ph.D. in laboratory of Michael Caplan at Yale University, where she studied both renal physiology and sensory biology

Yamina's Corner Expert strategic and scientific consultancy for GPCR-focused biotechs, VCs, and CROs. Get Team Access GPCR University Expert-led courses spanning GPCR drug discovery — from receptor biology Corner Timeline Strategy Strategic workshops that replace trial-and-error with proven frameworks for biotech Visibility for Solution Providers Strategic media partnerships that connect your company with biotech Wherever you are in your discovery journey, the Foundry helps GPCR biotech companies move faster and

GPCR Ecosystem: uniting scientists, biotech, and innovators to advance GPCR research worldwide. Who We Are We are a global network of scientists, biotech innovators, pharma professionals, CRO leaders & Get Our Weekly News See Why it Matters 6,600+ followers 200+ Research Labs 1,500+ Scientists 50+ Biotech Now, it's a global ecosystem of scientists, biotech teams, CRO leaders, and trainees working to move Premium Members Include: ✔ Drug hunters at early-stage biotechs ✔ CRO leaders building assays and tools

Frequently asked questions Webinar University Vault Premium Pricing GPCR Masterclass YC-Biotech YC-VC GPCR webinars are live online scientific sessions focused on G protein-coupled receptor (GPCR) biology Translational scientists Biotech and pharmaceutical researchers Postdoctoral fellows and graduate researchers The content is highly relevant for biotech and pharmaceutical scientists. These programs are designed for scientists seeking advanced, mechanism-focused training in GPCR biology

GPCRs are among the most powerful and complex targets in biomedical research. Elodie Dupuis earned her Master’s degree in biology and biotechnology engineering from the University Mathis holds a biotechnology engineering degree from the National School of Biomolecule Technology of Bordeaux and an MS in biomedical business management from the Grenoble School of Management. Internalization is a core—but often overlooked—dimension of GPCR biology.

As a CRO partner, you'll gain trusted access to an engaged audience of biotech teams and drug discovery partner, you'll be featured across our nonprofit platform, trusted by thousands of GPCR scientists and biotech Social Media Promotion Engaging posts about your organization targeted to GPCR researchers and biotech

David Sykes " David Andrew Sykes, BSc Hons Pharmacology, MSc Molecular Biology and Biochemistry, PhD

She received her BSc in Human Biology from King’s College London in 1997, and while her Ph.D. commenced Her research focuses on understanding the fundamental cell biological mechanisms regulating GPCR activity Her work is currently funded by Biotechnology and Biological Sciences Research Council (BBSRC), Diabetes

Her work spans GPCR structural biology, membrane protein stabilization, allosteric modulation, and the Marshall in the room — a new category of GPCR biology opened, with heterodimers as obligate signaling Years of assumed peptide biology dissolved into a simpler truth hidden in the solvent. Oncology Ignored GPCRs for Decades — and Is Paying Attention Now Twenty years ago, cancer biologists Richard Henderson at the Laboratory of Molecular Biology in Cambridge, UK.

Her work integrates bioinformatics, protein modeling, and experimental collaboration to support GPCR GPCR Biology Continues to Produce “Gotcha Moments” Despite decades of research, GPCRs remain complex How bioengineering and bioinformatics led Dr. I studied bioengineering in Brussels, and during my master’s I was introduced to bioinformatics. How do you see the role of computational approaches in GPCR biology?

After earning her undergraduate degree in biochemistry from the University of Michigan, she deferred

Terry Hebert explains why studying GPCRs in HEK293 cells misses critical biology — and how iPSC-derived His lab develops BRET- and FRET-based biosensors that produce different conformational outputs depending His research centers on GPCR signaling networks, biosensor development, and the role of cellular context Trained in microbiology and ion channel biology at the University of Toronto, he transitioned to GPCRs His lab develops resonance energy transfer-based biosensors and applies them in induced pluripotent stem

He leads a multidisciplinary research team comprising biologists, chemists, physicists, engineers and journals such as Nature, Cell, New England Journal of Medicine, Journal of Clinical Investigation, PLoS Biology

Demet Araç "Demet was an undergraduate at Bilkent University in Turkey, where she majored in Molecular Biology , Demet began her independent research career at the University of Chicago within the Department of Biochemistry and Molecular Biology." Demet shared that his interest in science led him to study biology, genetics, and molecular biophysics Demet shared his belief that he was driven by a biological need to tackle more challenging tasks.

Oliver Hartley Oliver Hartley is VP for Drug Discovery at Orion Biotechnology . Trained as a biochemist, he completed a PhD in protein engineering (Cambridge, UK) with Sir Gregory Winter Oliver Hartley on the web LinkedIn Orion Biotechnology Dr. GPCR Ecosystem Unlock the Full Dr.

When Sam Hoare and the CRF receptor team at Neurocrin Biosciences discovered that their lead compound perspective to GPCR pharmacology — one trained in allosteric modulation, sharpened in Class B receptor biology For Hoare, the unsolved problem isn't the biology — it's the math no one wrote down. Hoare now consults for biotech and pharmaceutical clients on GPCR data analysis, receptor binding kinetics He guided the in vitro biology efforts of the company for numerous drug discovery campaigns.

Her group works at the intersection of neuropeptide signaling, behavioral genetics, and vector biology About Laura Duvall runs a research lab in the Department of Biological Sciences at Columbia University

Foord reflects on his path from academic neuroendocrinology to introducing molecular biology and molecular pharmacology into Glaxo’s GPCR programs, and on the combination of rigor, bioinformatics, and serendipity Deorphanizing Receptors Blends Bioinformatics and Bench Work . Dr. As Head of Bioinformatics for Neuroscience, Dr. Reflecting on his path from physiology to molecular pharmacology to bioinformatics, Dr.

We moved to Salt Lake City, Utah in 2020 to begin his own laboratory in the Department of Biochemistry broad questions in pharmacology, with a specific focus on G-protein coupled receptor signaling and biology

GPCR Ecosystem About Monserrat Avila Zozaya I am a cell biologist interested in studying GPCRs, especially Berchiche obtained her Master’s and Ph.D. in Biochemistry at the University of Montreal in Canada before expertise over the past two decades studying structure/function relationships of GPCRs using live-cell bioluminescence

Berchiche obtained her Master’s and Ph.D. in Biochemistry at the University of Montreal in Canada before expertise over the past two decades studying structure/function relationships of GPCRs using live-cell bioluminescence

Tom Sakmar's lab, CRISPR knockout generation at NIAID, and class B peptide receptor work at Generate Biomedicines She holds a PhD in Biochemistry from the Université de Montréal, where she trained in Dr. research fellowship in B-cell molecular immunology at NIAID, and a senior scientist role at Generate Biomedicines outside clinical attention Career architecture for bench pharmacologists moving beyond academia and biotech GPCR was founded in March 2020 after a COVID-era redundancy at Generate Biomedicines.

Pittsburgh and continued her postdoctoral research at the University of Vermont studying cellular signaling, biosensors Nyla supports biomedical research by connecting researchers with resources and promoting reproducible I completed my Ph.D. in molecular and cell biology at UConn and then joined Addgene as a Quality Control